about
Human NKG2D-ligands: cell biology strategies to ensure immune recognitionGenome-wide association study in alopecia areata implicates both innate and adaptive immunityFine tuning a well-oiled machine: Influence of NK1.1 and NKG2D on NKT cell development and functionA novel system of polymorphic and diverse NK cell receptors in primatesStructure of the HCMV UL16-MICB Complex Elucidates Select Binding of a Viral Immunoevasin to Diverse NKG2D LigandsA Selection Fit Mechanism in BMP Receptor IA as a Possible Source for BMP Ligand-Receptor PromiscuityCrystal Structure of the Cowpox Virus-Encoded NKG2D Ligand OMCPGeneration, affinity maturation, and characterization of a human anti-human NKG2D monoclonal antibody with dual antagonistic and agonistic activityCellular expression, trafficking, and function of two isoforms of human ULBP5/RAET1G.Interleukin-21 induces the differentiation of human umbilical cord blood CD34-lineage- cells into pseudomature lytic NK cells.Two novel human cytomegalovirus NK cell evasion functions target MICA for lysosomal degradationNK cells and gammadelta T cells mediate resistance to polyomavirus-induced tumors.Control of Tumor Initiation by NKG2D Naturally Expressed on Ovarian Cancer Cells.The NKG2D ligands RAE-1δ and RAE-1ε differ with respect to their receptor affinity, expression profiles and transcriptional regulation.Modulation of natural killer cells by human cytomegalovirus.Distinct expression profile of HCMV encoded miRNAs in plasma from oral lichen planus patients.NKG2D ligand overexpression in lupus nephritis correlates with increased NK cell activity and differentiation in kidneys but not in the periphery.Recognition of adult and pediatric acute lymphoblastic leukemia blasts by natural killer cells.Murine trophoblast cells induce NK cell interferon-gamma production through KLRK1The effect of photodynamic therapy on tumor cell expression of major histocompatibility complex (MHC) class I and MHC class I-related moleculesCervical cancer cell lines expressing NKG2D-ligands are able to down-modulate the NKG2D receptor on NKL cells with functional implicationsAutonomous stimulation of cancer cell plasticity by the human NKG2D lymphocyte receptor coexpressed with its ligands on cancer cells.Opportunities and limitations of natural killer cells as adoptive therapy for malignant diseaseRegulation of ligands for the NKG2D activating receptor.Thymoglobulin, interferon-γ and interleukin-2 efficiently expand cytokine-induced killer (CIK) cells in clinical-grade cultures.NKG2D is required for NK cell activation and function in response to E1-deleted adenovirusGene number determination and genetic polymorphism of the gamma delta T cell co-receptor WC1 genes.Genetics, genomics, and evolutionary biology of NKG2D ligands.Expansions of NK-like αβT cells with chronologic aging: novel lymphocyte effectors that compensate for functional deficits of conventional NK cells and T cells.Natural killer cells from children with type 1 diabetes have defects in NKG2D-dependent function and signalingExpression, signaling proficiency, and stimulatory function of the NKG2D lymphocyte receptor in human cancer cells.Natural killer cell function, an important target for infection and tumor protection, is impaired in type 2 diabetesImmune aging and autoimmunity.Broad MICA/B expression in the small bowel mucosa: a link between cellular stress and celiac disease.MICA/B and ULBP1 NKG2D ligands are independent predictors of good prognosis in cervical cancer.PRL-3 mediates the protein maturation of ULBP2 by regulating the tyrosine phosphorylation of HSP60NKG2D contributes to efficient clearance of picornavirus from the acutely infected murine brainIntestinal intraepithelial lymphocyte activation promotes innate antiviral resistanceVaricella-Zoster Virus and Herpes Simplex Virus 1 Differentially Modulate NKG2D Ligand Expression during Productive Infection.Immunomodulation of Selective Naive T Cell Functions by p110δ Inactivation Improves the Outcome of Mismatched Cell Transplantation.
P2860
Q21131219-545F44D6-692A-4123-A0D2-DC75079B9C6FQ24632461-6967B106-F7D3-4372-8A51-1B706FDDA213Q26830239-4D51B377-17CF-49BC-A665-CAE390DAC848Q27348758-612CF199-8A6B-4819-84CA-71632C635223Q27659082-78A86311-D04F-47F8-B36D-37ECB973AC83Q27664939-5DB27973-C4C2-4BDD-9DAF-80271E4C3EA7Q27674864-2D7CBA65-E00C-41D4-A010-5FF1EBD349A8Q33371167-A1BD98C8-0BAE-44D2-8FFC-A0E806D47E44Q33410094-52457EFC-2EDE-4DF3-A205-862E4D03F919Q33497623-EABA1074-1AE1-4546-88F6-E5F640E666B4Q33553680-AFFDD112-B4CD-4F01-959C-9AE67A2A6649Q33594446-D10C0CE9-95E6-48BF-A251-8F8E18627B99Q33676231-7ABEA444-90B3-4247-9701-62FCC7159CAFQ33728181-DADCEEFD-2384-4324-B70D-1E3AA73CFC9BQ33744384-12B603DF-9F04-411E-AD57-46D436C71CF9Q33776574-FAC916A0-2EA2-43C3-9351-88EE63DCE9DFQ33816779-1F36B1D9-1CD6-4950-9046-B0F54A688540Q33828594-1F792A85-65A5-422F-AF44-721BB51B9A56Q34076708-D90AE7E9-C5DC-46F8-8BB3-79B50BD5453CQ34128134-EA651766-387F-4EBC-A64D-8B051BD5049EQ34153620-931AD2BF-1299-4ABD-8878-5E85AA69AA4BQ34301698-528A81E7-131A-4DDE-803C-BDA418808E37Q34307792-FC479BCA-4159-47AB-8677-74DC255DDDEAQ34321457-864BF6D4-670B-4101-B703-211DEACA9E45Q34419059-D3C3DE8A-A370-4FD9-B27F-A9FD99B638D6Q34432661-35B8BF9F-6231-4CFC-9599-A5E18AB42C17Q34448449-EE884F3F-09EE-41DF-81A0-FF7E0420A817Q34489980-686E3D10-E95B-47A8-9A2F-AA29CA9803BDQ34577195-DCBE49FC-EAE1-44CB-94F2-7C934785913CQ34615448-D5928938-FC52-4E8A-B27D-257F22F80425Q34652549-ECB587E6-DDA3-418A-BF09-11135F52C029Q34701422-ACBFF601-9CFA-4384-BF50-5FC111C42042Q34777989-F4558DCF-F49A-4238-8BD2-81427B030A09Q34994384-C9FB4820-391E-4BEE-9EFA-066FC8112FAAQ34995302-272978C9-7D17-4B81-AC45-1B8DF4880A06Q35163691-8DDEFFAB-27CC-48B9-8323-B0A11ACCAA3FQ35235018-9A10E34B-A7D9-449A-8100-42E7D5B0DDC0Q35775433-913B93DC-52E7-407B-B309-4F6EFE629D67Q35861220-9DA816B9-2ABA-47E6-8C64-00189A7CE83CQ35973413-3703025B-9720-49F3-A4BC-BE25A67AF8DA
P2860
description
2007 nî lūn-bûn
@nan
2007年の論文
@ja
2007年論文
@yue
2007年論文
@zh-hant
2007年論文
@zh-hk
2007年論文
@zh-mo
2007年論文
@zh-tw
2007年论文
@wuu
2007年论文
@zh
2007年论文
@zh-cn
name
Promiscuity and the single receptor: NKG2D.
@en
type
label
Promiscuity and the single receptor: NKG2D.
@en
prefLabel
Promiscuity and the single receptor: NKG2D.
@en
P356
P1476
Promiscuity and the single receptor: NKG2D.
@en
P2093
John Trowsdale
Robert A Eagle
P304
P356
10.1038/NRI2144
P577
2007-08-03T00:00:00Z